José A. Hidalgo
Harvard University(US)Massachusetts General Hospital(US)Via Libre(PE)Hospital de Sabadell(ES)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk
Most-Cited Works
- → Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials(2018)373 cited
- → Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial(2019)193 cited
- → Risk of cancers during interrupted antiretroviral therapy in the SMART study(2007)136 cited
- → Submandibular gland needle biopsy for the diagnosis of Parkinson disease(2014)130 cited
- → Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease(2013)114 cited
- → Striatal Amyloid Plaque Density Predicts Braak Neurofibrillary Stage and Clinicopathological Alzheimer's Disease: Implications for Amyloid Imaging